Arthur Higgins | President, Chief Executive Officer |
Dan Peisert | Senior Vice President, Chief Financial Officer |
John Thomas | Senior Vice President of Investor Relations & Corporate Communications |
Scott Henry | Roth Capital |
Dan Busby | RBC Capital Markets |
Irina Koffler | Mizuho |
David Amsellem | Piper Jaffray |
Good day, ladies and gentlemen, and welcome to the Assertio Therapeutics, Q4 2018 Earnings Conference Call. At this time all participants are in a listen-only mode.
Following management’s prepared remarks we will have a question-and-answer session and instructions will be given at that time. [Operator Instructions].
As a reminder, today’s conference will be recorded.